FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311421887> ?p ?o ?g. }

• W4311421887 endingPage "100648" @default.
• W4311421887 startingPage "100648" @default.
• W4311421887 abstract "Biliary tract cancer (BTC) is associated with a dismal prognosis, partly because it is typically diagnosed late, highlighting the need for diagnostic biomarkers. The purpose of this project was to identify and validate multiprotein signatures that could differentiate patients with BTC from non-cancer controls.In this study, we included treatment-naïve patients with BTC, healthy controls, and patients with benign conditions including benign biliary tract disease. Participants were divided into three non-overlapping cohorts: a case-control-based discovery cohort (BTC = 186, controls = 249); a case-control-based validation cohort (validation cohort 1: BTC = 113, controls = 241); and a cohort study-based validation cohort including participants (BTC = 8, controls = 132) referred for diagnostic work-up for suspected cancer (validation cohort 2). Immuno-Oncology (I-O)-related proteins were measured in serum and plasma using a proximity extension assay (Olink Proteomics). Lasso and Ridge regressions were used to generate protein signatures of I-O-related proteins and carbohydrate antigen 19-9 (CA19-9) in the discovery cohort.Sixteen protein signatures, including 2 to 82 proteins, were generated. All signatures included CA19-9 and chemokine C-C motif ligand 20. Signatures discriminated between patients with BTC vs. controls, with AUCs ranging from 0.95 to 0.99 in the discovery cohort and 0.94 to 0.97 in validation cohort 1. In validation cohort 2, AUCs ranged from 0.84 to 0.94. Nine signatures achieved a specificity of 82% to 84% while keeping a sensitivity of 100% in validation cohort 2. All signatures performed better than CA19-9, and signatures including >15 proteins showed the best performance.The study demonstrated that it is possible to generate protein signatures that can successfully differentiate patients with BTC from non-cancer controls.We attempted to find blood sample-based protein profiles that could differentiate patients with biliary tract cancer from those without cancer. Several profiles were found and tested in different groups of patients. The profiles were successful at identifying most patients with biliary tract cancer, pointing towards the utility of multiprotein signatures in this context." @default.
• W4311421887 created "2022-12-26" @default.
• W4311421887 creator A5032091314 @default.
• W4311421887 creator A5036546967 @default.
• W4311421887 creator A5040739416 @default.
• W4311421887 creator A5046731425 @default.
• W4311421887 creator A5063670944 @default.
• W4311421887 creator A5066543715 @default.
• W4311421887 creator A5071985590 @default.
• W4311421887 creator A5074060343 @default.
• W4311421887 creator A5082891908 @default.
• W4311421887 creator A5089273813 @default.
• W4311421887 creator A5090876784 @default.
• W4311421887 date "2023-03-01" @default.
• W4311421887 modified "2023-09-26" @default.
• W4311421887 title "Development and validation of circulating protein signatures as diagnostic biomarkers for biliary tract cancer" @default.
• W4311421887 cites W1278288886 @default.
• W4311421887 cites W1757407923 @default.
• W4311421887 cites W2001008402 @default.
• W4311421887 cites W2005990567 @default.
• W4311421887 cites W2009637031 @default.
• W4311421887 cites W2010084870 @default.
• W4311421887 cites W2019694480 @default.
• W4311421887 cites W2031293709 @default.
• W4311421887 cites W2081493969 @default.
• W4311421887 cites W2097360283 @default.
• W4311421887 cites W2140559938 @default.
• W4311421887 cites W2181064420 @default.
• W4311421887 cites W2189125461 @default.
• W4311421887 cites W2204289602 @default.
• W4311421887 cites W2309818502 @default.
• W4311421887 cites W2328176404 @default.
• W4311421887 cites W2337387091 @default.
• W4311421887 cites W2346128621 @default.
• W4311421887 cites W2396025063 @default.
• W4311421887 cites W2397386687 @default.
• W4311421887 cites W2411225414 @default.
• W4311421887 cites W2560087117 @default.
• W4311421887 cites W2593500728 @default.
• W4311421887 cites W2619076775 @default.
• W4311421887 cites W2788729882 @default.
• W4311421887 cites W2792957919 @default.
• W4311421887 cites W2796151429 @default.
• W4311421887 cites W2809857443 @default.
• W4311421887 cites W2885738414 @default.
• W4311421887 cites W2910397725 @default.
• W4311421887 cites W2920885512 @default.
• W4311421887 cites W2921127436 @default.
• W4311421887 cites W2942656542 @default.
• W4311421887 cites W2947521241 @default.
• W4311421887 cites W2952624934 @default.
• W4311421887 cites W3012883759 @default.
• W4311421887 cites W3043853060 @default.
• W4311421887 cites W3084727392 @default.
• W4311421887 cites W3094474760 @default.
• W4311421887 cites W3121418202 @default.
• W4311421887 cites W3124058635 @default.
• W4311421887 cites W3136665739 @default.
• W4311421887 cites W3137224153 @default.
• W4311421887 cites W3141120120 @default.
• W4311421887 cites W4211025847 @default.
• W4311421887 cites W4283774266 @default.
• W4311421887 cites W4308986104 @default.
• W4311421887 cites W2912562816 @default.
• W4311421887 doi "https://doi.org/10.1016/j.jhepr.2022.100648" @default.
• W4311421887 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36699667" @default.
• W4311421887 hasPublicationYear "2023" @default.
• W4311421887 type Work @default.
• W4311421887 citedByCount "1" @default.
• W4311421887 countsByYear W43114218872023 @default.
• W4311421887 crossrefType "journal-article" @default.
• W4311421887 hasAuthorship W4311421887A5032091314 @default.
• W4311421887 hasAuthorship W4311421887A5036546967 @default.
• W4311421887 hasAuthorship W4311421887A5040739416 @default.
• W4311421887 hasAuthorship W4311421887A5046731425 @default.
• W4311421887 hasAuthorship W4311421887A5063670944 @default.
• W4311421887 hasAuthorship W4311421887A5066543715 @default.
• W4311421887 hasAuthorship W4311421887A5071985590 @default.
• W4311421887 hasAuthorship W4311421887A5074060343 @default.
• W4311421887 hasAuthorship W4311421887A5082891908 @default.
• W4311421887 hasAuthorship W4311421887A5089273813 @default.
• W4311421887 hasAuthorship W4311421887A5090876784 @default.
• W4311421887 hasBestOaLocation W43114218871 @default.
• W4311421887 hasConcept C121608353 @default.
• W4311421887 hasConcept C126322002 @default.
• W4311421887 hasConcept C142724271 @default.
• W4311421887 hasConcept C143998085 @default.
• W4311421887 hasConcept C2780258809 @default.
• W4311421887 hasConcept C2781197716 @default.
• W4311421887 hasConcept C3017919176 @default.
• W4311421887 hasConcept C55493867 @default.
• W4311421887 hasConcept C71924100 @default.
• W4311421887 hasConcept C72563966 @default.
• W4311421887 hasConcept C86803240 @default.
• W4311421887 hasConceptScore W4311421887C121608353 @default.
• W4311421887 hasConceptScore W4311421887C126322002 @default.
• W4311421887 hasConceptScore W4311421887C142724271 @default.
• W4311421887 hasConceptScore W4311421887C143998085 @default.

• next